Regeneron pharmaceuticals, inc. (regn) investors who lost money have opportunity to lead securities fraud lawsuit

Los angeles , jan. 17, 2025 /prnewswire/ -- the law offices of frank r. cruz announces that investors with losses related to regeneron pharmaceuticals, inc. ("regeneron" or the "company") (nasdaq: regn) have opportunity to lead the securities fraud class action lawsuit.

REGN Ratings Summary

REGN Quant Ranking